A. Neubauer et al., Mutations within the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH do not account for its attenuation, BERL MUN TI, 112(9), 1999, pp. 351-354
Citations number
16
Categorie Soggetti
Veterinary Medicine/Animal Health
Journal title
BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT
The equine herpesvirus 1 (EHV-1) modified live vaccine strain RacH is apath
ogenic for both laboratory animals and the natural host. The apathogenicity
of RacH was caused by serial passages of the virus in heterologous cells.
When compared to the virulent parental strain RacL11 several changes in the
RacH genome occured. Previous results have shown that the loss of the IR6
gene correlated with the loss of virulence. Additional important mutations
were observed within the US2 gene which is directly adjacent to the IR6 gen
e and within the glycoprotein B (gB) gene. To answer the question whether t
hese mutations contribute to the attenuation of RacH several recombinant EH
V-1 were constructed: The mutated genes in RacH were replaced by the wild-t
ype US2 gene or the wild-type gB gene, respectively. In addition, a RacL11
recombinant expressing the mutated (RacH) gB instead of the wild-type gene
was generated. All recombinant viruses were tested for virulence using the
EHV-1 mouse model. The results were as follows: i) The insertion of the Rac
L11 US2 gene into the RacH virus did not restore virulence and none of the
infected mice showed typical signs of EHV-l-caused disease (symptoms and bo
dy weight loss), ii) Exchanging gB genes between RacL11 and RacH did not al
ter their virulence phenotypes remarkably either. Therefore, it is conclude
d that attenuation of the EHV-I vaccine strain RacH is caused solely by the
absence of the IR6 gene and protein.